Practical considerations in future psoriasis therapies

Dermatologic Clinics

Volumn 22, Issue 4, 2004, Pages 487-492

  Riddle, Christy ^a   Young, Melodie ^b,c   Menter, Alan ^a,c  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^c Texas Dermatology Associates PA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ADRENALIN; ALEFACEPT; CYCLOSPORIN; DIPHENHYDRAMINE; EFALIZUMAB; ETANERCEPT; ETRETINATE; HYDROXYUREA; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXYGEN; PARACETAMOL; PIMECROLIMUS; PREDNISONE; PSORALEN; STEROID; TAZAROTENE; TIOGUANINE; TRIAMCINOLONE;

CHILL; DRUG COST; DRUG INDICATION; FLU LIKE SYNDROME; HEALTH CARE COST; HUMAN; INFECTION; INJECTION SITE; MEDICAL SPECIALIST; NEUROTOXICITY; NURSE; PATIENT CARE; PRACTICE GUIDELINE; PREMEDICATION; PRIORITY JOURNAL; PSORIASIS; REBOUND; REVIEW; SIDE EFFECT; TREATMENT PLANNING;

COMBINED MODALITY THERAPY; DERMATOLOGY; FEMALE; FORECASTING; HUMANS; MALE; PSORIASIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 4344699978     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(03)00128-1     Document Type: Review

References (5)

1. Koo J., Menter A. The Koo-Menter psoriasis instrument for identifying candidate patients for systemic therapy. Psoriasis Forum, Summer 2003. p. 6-9
2. Craze M., Young M. Integrating biologic therapies into a dermatology practice: practical and economic considerations. J Am Acad Dermatol. 49:2003;S139-S142
3. Chaudhari U., Romano P., Mulcahy L.D., Dooley L.T., Baker D.G., Gottlieb A.B. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomized trial. Lancet. 357:2001;1842-1847
4. Lipsky P.E., Van der Heijde D., St. Clair W., Furst D.E., Breedveld F.C., Kalden J.R., et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med. 343:2000;1594-1602
5. Cheifetz A., Smedley M., Martin S., Reiter M., Leone G., Mayer L., et al. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol. 98:2003;1315-1324